Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
How long should therapy continue for patients with HH?
This version of the course is no longer available.
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
Hereditary Hemochromatosis
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Hereditary Hemochromatosis (online CE course)
How long should therapy continue for patients with HH?
Please select the single best answer
Therapy should continue throughout the lifetime.
Therapy should continue only until ferritin levels have returned to normal.
Therapy should continue for one year only.
X
×